Eton Pharmaceuticals (ETON) Construction in Progress (2018 - 2022)

Eton Pharmaceuticals has disclosed Construction in Progress across 4 years of filings, most recently posting $12000.0 for Q4 2022.

• Construction in Progress for Q4 2022 came in at $12000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $12000.0 (changed N/A YoY), and the FY2022 annual result was $12000.0, changed N/A from the prior year.
• Construction in Progress came in at $12000.0 for Q4 2022 at Eton Pharmaceuticals, roughly flat from $12000.0 in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $873000.0 in Q1 2019 to a low of $1000.0 in Q3 2020.
• The 4-year median for Construction in Progress is $10500.0 (2019), against an average of $175750.0.
• Peak annual rise in Construction in Progress reached 66.67% in 2020, while the deepest fall reached 99.54% in 2020.
• Eton Pharmaceuticals' Construction in Progress stood at $492000.0 in 2018, then tumbled by 98.17% to $9000.0 in 2019, then plunged by 88.89% to $1000.0 in 2020, then jumped by 1100.0% to $12000.0 in 2022.
• The last three Construction in Progress figures came in at $12000.0 (Q4 2022), $12000.0 (Q1 2022), and $1000.0 (Q3 2020), per Business Quant data.